VNRX · VolitionRX Ltd
United States · RS rating 5 · As of 2026-11-03
| Price | 0.19 USD |
|---|---|
| 1-day change | -8.1% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 26 / 3 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 1 / 32 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +12.4% |
| Sales growth Q/Q | -28.7% |
| Distance from 52-week high | +97.9% |
| Market cap (USD) | $19.5M |